Evidence map›Paper›PMID 29514609›Full record

ArticleBMC infectious diseases2018

Public health impact and cost effectiveness of routine childhood vaccination for hepatitis a in Jordan: a dynamic model approach.

Wail A Hayajneh, Vincent J Daniels, Cerise K James, Muhammet Nabi Kanıbir, Matthew Pilsbury, Morgan Marks, Michelle G Goveia, Elamin H Elbasha, Erik Dasbach, Camilo J Acosta

Erratum issuedOpen access · goldAbstract read
In one paragraph

Article in BMC infectious diseases, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 10 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed, 2 pooled it
1.1field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 2 syntheses or guidelines pooled it, 16 citations in OpenAlex.

  1. Pooled it
  2. Systematic Literature Review of Health Impact Assessments in Low and Middle-Income Countries.International journal of environmental research and public health · 2019
    Pooled it
  3. Review
  4. Hepatitis A virus endemicity and vaccine policy, India.Bulletin of the World Health Organization · 2026
    Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 2 countries.

Wail A HayajnehDepartment of Pediatrics, Faculty of Medicine, Jordan University of Science and Technology, PO Box 3030, Irbid, 22110, Jordan. wailh@just.edu.jo.ORCID http://orcid.org/0000-0003-1816-9018
Vincent J DanielsMerck & Co., Inc., Kenilworth, NJ, USA.
Cerise K JamesAgile-1 for Merck & Co., Inc., Kenilworth, NJ, USA.
Muhammet Nabi KanıbirMerck & Co., Inc., Kenilworth, NJ, USA.
Matthew PilsburyMerck & Co., Inc., Kenilworth, NJ, USA.
Morgan MarksMerck & Co., Inc., Kenilworth, NJ, USA.
Michelle G GoveiaMerck & Co., Inc., Kenilworth, NJ, USA.
Elamin H ElbashaMerck & Co., Inc., Kenilworth, NJ, USA.
Erik DasbachMerck & Co., Inc., Kenilworth, NJ, USA.
Camilo J AcostaMerck & Co., Inc., Kenilworth, NJ, USA.
Merck & Co., Inc., Rahway, NJ, USA (United States) · USJordan University of Science and Technology · JO

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundAs the socioeconomic conditions in Jordan have improved over recent decades the disease and economic burden of Hepatitis A has increased. The purpose of this study is to assess the potential health and economic impact of a two-dose hepatitis A vaccine program covering one-year old children in Jordan.

methodsWe adapted an age-structured population model of hepatitis A transmission dynamics to project the epidemiologic and economic impact of vaccinating one-year old children for 50 years in Jordan. The epidemiologic model was calibrated using local data on hepatitis A in Jordan. These data included seroprevalence and incidence data from the Jordan Ministry of Health as well as hospitalization data from King Abdullah University Hospital in Irbid, Jordan. We assumed 90% of all children would be vaccinated with the two-dose regimen by two years of age. The economic evaluation adopted a societal perspective and measured benefits using the quality-adjusted life-year (QALY).

resultsThe modeled vaccination program reduced the incidence of hepatitis A in Jordan by 99%, 50 years after its introduction. The model projected 4.26 million avoided hepatitis A infections, 1.42 million outpatient visits, 22,475 hospitalizations, 508 fulminant cases, 95 liver transplants, and 76 deaths over a 50 year time horizon. In addition, we found, over a 50 year time horizon, the vaccination program would gain 37,502 QALYs and save over $42.6 million in total costs. The vaccination program became cost-saving within 6 years of its introduction and was highly cost-effective during the first 5 years.

conclusionA vaccination program covering one-year old children is projected to be a cost-saving intervention that will significantly reduce the public health and economic burden of hepatitis A in Jordan.

Indexed as

Cost-Benefit AnalysisModels, TheoreticalPublic HealthHepatitis AHepatitis A VaccinesHumansImmunization ProgramsInfantJordanQuality-Adjusted Life YearsVaccinationHepatitis A VaccinesCost-effectiveness analysisEconomicsHealth technology assessmentHepatitis aImmunizationImpactJordanSimulation

Identifiers

PMID29514609
PMCPMC5842652
OpenAlexW2801625702

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.